Current use and future development of gemtuzumab ozogamicin
- 31 July 2001
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 24-31
- https://doi.org/10.1016/s0037-1963(01)90153-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mini-allografts: ongoing trials in humansBone Marrow Transplantation, 2000
- Management of Acute Myeloid Leukemia in Elderly PatientsJournal of Clinical Oncology, 1999
- Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateBlood, 1999
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- Calicheamicin γ 1 I and DNA: Molecular Recognition Process Responsible for Site-SpecificityScience, 1989
- Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties.The Journal of Experimental Medicine, 1989
- Calichemicins, a novel family of antitumor antibiotics. 1. Chemistry and partial structure of calichemicin .gamma.1IJournal of the American Chemical Society, 1987
- Expression of normal myeloid-associated antigens by acute leukemia cellsBlood, 1986
- A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cellsLeukemia Research, 1984
- Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodiesBlood, 1983